Goodwin advised Tay on the agreement. Tay entered into a license agreement with VYNE Therapeutics, under which VYNE obtained exclusive rights to Tay’s oral BET inhibitor, TAY-B2...
Tay’s License Agreement with VYNE Therapeutics
KKR’s Acquisition of Additional Stake in Seiyu from Rakuten
Simpson Thacher & Bartlett advised KKR on the transaction. KKR, a leading global investment firm, and Rakuten Group, Inc., (“Rakuten”) announced the signing of definitive agreements...
Indotek’s Acquisition of Two Shopping Centres
Baker McKenzie advises Indotek on the deal. Indotek, international real estate fund based in Budapest, announced the acquisition of two shopping centres from Merlin Properties Socimi....
Bridgepoint’s Financing Acquisition of Windar Renovables
Linklaters has advised Bridgepoint on the deal. Bridgepoint, the british private equity firm, announced the financing for the acquisition of Windar Renovables, an asturian company belonging to...
Artex’s Acquisition of Allied Risk
McCann FitzGerald LLP advised Artex on the deal. Arthur J. Gallagher & Co. announced that its captive and alternative risk transfer solutions subsidiary, Artex Risk Solutions, Inc.,...
Ulmer Posthöfe GmbH’s Acquisition of Office Complex from Demire
CMS advised Ulmer Posthöfe GmbH, part of Merckle Group, on the deal. Ulmer Posthöfe GmbH, part of the real estate arm of the Merckle Group, has...
Bow-mark Capital LLP’s Acquisition of Solvians Group
CMS advised founder Thomas Schwanhäuser on the deal. Founder Thomas Schwanhäuser announced the sale of all shares in Solvians Group to Bow-mark Capital LLP, a London-based private...
Krauss-Maffei Wegmann’s Dispute with Rheinmetall
Oppenhoff advised Krauss-Maffei Wegmann (KMW) on the deal. KMW announced a dispute concerning statements made by Armin Papperger, CEO of Rheinmetall AG. The high-profile proceedings before the...